These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 25280976

  • 1. Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children.
    Bernard E, Goutelle S, Bertrand Y, Bleyzac N.
    Ann Pharmacother; 2014 Dec; 48(12):1580-4. PubMed ID: 25280976
    [Abstract] [Full Text] [Related]

  • 2. Nicardipine as antihypertensive therapy in liver transplant recipients: results of long-term use.
    Duvoux C, Cherqui D, Di Martino V, Métreau JM, Salvat A, Lauzet JY, Fagniez PL, Dhumeaux D.
    Hepatology; 1997 Feb; 25(2):430-3. PubMed ID: 9021959
    [Abstract] [Full Text] [Related]

  • 3. Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study.
    Pesavento TE, Jones PA, Julian BA, Curtis JJ.
    J Am Soc Nephrol; 1996 Jun; 7(6):831-5. PubMed ID: 8793790
    [Abstract] [Full Text] [Related]

  • 4. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G.
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [Abstract] [Full Text] [Related]

  • 5. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC, Koomans HA.
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [Abstract] [Full Text] [Related]

  • 6. [Lacidipine efficacy and safety for high blood pressure treatment in pediatric oncohematology].
    Bernard E, Mialou V, Dony A, Garnier N, Renard C, Bleyzac N.
    Arch Pediatr; 2014 Oct; 21(10):1101-5. PubMed ID: 25125033
    [Abstract] [Full Text] [Related]

  • 7. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients.
    Rodicio JL.
    J Cardiovasc Pharmacol; 2000 Oct; 35(3 Suppl 1):S7-11. PubMed ID: 11347860
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic interaction between oral cyclosporin and mibefradil in stabilized post-renal-transplant patients.
    Spoendlin M, Peters J, Welker H, Bock A, Thiel G.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1787-91. PubMed ID: 9681729
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Li TF, Hu L, Ma XL, Huang L, Liu XM, Luo XX, Feng WY, Wu CF.
    Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
    Lapointe N, Chen H, Qi S, Xu D, Daloze P, Dumont L.
    Eur Surg Res; 1999 Dec; 31(3):259-66. PubMed ID: 10352354
    [Abstract] [Full Text] [Related]

  • 11. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.
    Chanard J, Toupance O, Lavaud S, Hurault de Ligny B, Bernaud C, Moulin B.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2147-53. PubMed ID: 13679494
    [Abstract] [Full Text] [Related]

  • 12. A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
    Atiq F, Broers AE, Andrews LM, Doorduijn JK, Koch BC, Van Gelder T, Versmissen J.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):719-23. PubMed ID: 26965514
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic drug interaction between cyclosporine and imatinib in bone marrow transplant children and model-based reappraisal of imatinib drug interaction profile.
    Bleyzac N, Kebaili K, Mialou V, Bertrand Y, Goutelle S.
    Ther Drug Monit; 2014 Dec; 36(6):724-9. PubMed ID: 24739665
    [Abstract] [Full Text] [Related]

  • 14. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
    Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ.
    Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629
    [Abstract] [Full Text] [Related]

  • 15. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A.
    Radwan-Oczko M, Boratyńska M, Klinger M, Zietek M.
    Ann Transplant; 2003 Nov; 8(4):57-62. PubMed ID: 15171009
    [Abstract] [Full Text] [Related]

  • 16. [Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014)].
    Valenzuela R, Torres JP, Salas C, Gajardo I, Palma J, Catalán P, Santolaya ME, Morales J.
    Rev Chilena Infectol; 2017 Feb; 34(1):14-18. PubMed ID: 28394976
    [Abstract] [Full Text] [Related]

  • 17. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant.
    Leenen FH, Coletta E, Davies RA.
    Am J Cardiol; 2007 Aug 01; 100(3):531-5. PubMed ID: 17659942
    [Abstract] [Full Text] [Related]

  • 18. Lacidipine protects against cyclosporine-induced nephrotoxicity in rats.
    Naidu MU, Kumar KV, Shifow AA, Prayag A, Ratnakar KS.
    Nephron; 1999 Jan 01; 81(1):60-6. PubMed ID: 9884421
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR.
    Am J Med; 1991 May 17; 90(5A):32S-36S. PubMed ID: 2039018
    [Abstract] [Full Text] [Related]

  • 20. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM, Hagan ME, Crompton JA, Gilbert EM.
    J Heart Lung Transplant; 2005 Dec 17; 24(12):2144-7. PubMed ID: 16364863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.